Mannitol dry powder for inhalation for treating cystic fibrosis

  • Technology appraisal guidance
  • TA266
  • Published: 
Download guidance (PDF)

8 Review of guidance

8.1 The guidance on this technology will be considered for review in October 2015. The Guidance Executive will decide whether the technology should be reviewed based on information gathered by NICE, and in consultation with consultees and commentators.

Andrew Dillon
Chief Executive
November 2012